Related Experiment Video
Updated: Feb 9, 2026

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
Published on: March 10, 2023
First Report of β-Thalassemia Intermedia in a Patient Compound Heterozygous for -92 (C>T) and Codons 36/37 (-T)
Gunay Aliyeva1, Eldar Abdulalimov1, Chingiz Asadov1
1Department of Haemopoietic Pathologies, Institute of Haematology and Blood Transfusion, Baku, Azerbaijan.
Abstract:
The -92 (C>T) (HBB: c.-142C>T) is a silent β-thalassemia (β-thal) mutation previously described in combination with several β0 mutations and expressed as β-thal intermedia (β-TI). Heterozygous individuals are known to be completely asymptomatic showing borderline hemoglobin (Hb), mean corpuscular volume (MCV) and Hb A2 levels. Here, we report the first incidence of -92 in Eastern Europe and in Azerbaijan, and the first case in combination with codons 36/37 (-T) (HBB: c.112delT) mutation.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
β-Dicarbonyl Compounds via Crossed Claisen Condensations
Conjugate Addition to α,β-Unsaturated Carbonyl Compounds
Viral Mutations
Data Reporting and Recording

